98%
921
2 minutes
20
Objectives: To determine disparities in rates, length of stay (LOS) and hospital costs of potentially preventable hospitalisations (PPH) for selected chronic conditions among Aboriginal and non-Aboriginal South Australians (SA), then examine associations with area-level socioeconomic disadvantage and remoteness.
Setting: Period prevalence study using linked, administrative public hospital records.
Participants: Participants included all SA residents in 2005-2006 to 2010-2011. Analysis focused on those individuals experiencing chronic PPH as defined by the Australian Institute of Health and Welfare.
Primary Outcome Measures: Number and rates (unadjusted, then adjusted for sex and age) of chronic PPH, total LOS and direct hospital costs by Aboriginality.
Results: Aboriginal SAs experienced higher risk of index chronic PPH compared with non-Aboriginals (11.5 and 6.2 per 1000 persons per year, respectively) and at younger ages (median age 48 vs 70 years). Once hospitalised, Aboriginal people experienced more chronic PPH events, longer total LOS with higher costs than non-Aboriginal people (2.6 vs 1.9 PPH per person; 11.7 vs 9.0 days LOS; at $A17 928 vs $A11 515, respectively). Compared with population average LOS, the standardised rate ratio of LOS among Aboriginal people increased by 0.03 (95% CI 0.00 to 0.07) as disadvantage rank increased and 1.04 (95% CI 0.63 to 1.44) as remoteness increased. Non-Aboriginal LOS also increased as disadvantage increased but at a lower rate (0.01 (95% CI 0.01 to 0.01)). Costs of Aboriginal chronic PPH increased by 0.02 (95% CI 0.00 to 0.06) for each increase in disadvantage and 1.18 (95% CI 0.80 to 1.55) for increased remoteness. Non-Aboriginal costs also increased as disadvantage increased but at lower rates (0.01 (95% CI 0.01 to 0.01)).
Conclusion: Aboriginal people's heightened risk of chronic PPH resulted in more time in hospital and greater cost. Systematic disparities in chronic PPH by Aboriginality, area disadvantage and remoteness highlight the need for improved uptake of effective primary care. Routine, regional reporting will help monitor progress in meeting these population needs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652548 | PMC |
http://dx.doi.org/10.1136/bmjopen-2017-017331 | DOI Listing |
J Neuroeng Rehabil
July 2025
Rehabilitation Medicine Center, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
Background: Hand dysfunction significantly affects independence after stroke, with outcomes varying across individuals. Exploring biomarkers associated with the paretic hand can improve the prognosis and guide personalized rehabilitation. However, whether biomarkers derived from resting-state fMRI (rs-fMRI) can effectively classify and predict different hand outcomes and their biological mechanisms remain unclear.
View Article and Find Full Text PDFHeart Lung
June 2025
Instituto de Doenças do Tórax - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Background: Nocturnal hypoxemia (NH) negatively impacts the prognosis of several chronic cardiopulmonary diseases.
Objectives: To assess the risk factors associated with sustained NH in adults with precapillary pulmonary hypertension (pPH).
Methods: This cross-sectional study was performed between June 2021 and June 2024.
Hosp Pediatr
May 2025
Department of Community Child Health, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.
Objectives: Inequity in health outcomes for children and young people (CYP) from underserved populations (Indigenous, culturally and linguistically diverse, refugee and/or asylum seeking, out-of-home care backgrounds, and National Disability Insurance Scheme participants) persists. We quantify baseline inequities in health outcomes to measure the effectiveness of equity interventions.
Methods: We analyzed electronic medical records on CYP from the Sydney Children's Hospitals Network between 2015 and 2019.
Haemophilia
May 2025
Department of Obstetrics and Gynaecology, Katharine Dormandy Haemophilia and Thrombosis Centre, The Royal Free NHS Hospital and Institute for Women's Health, University College London, London, UK.
Introduction: Glanzmann's thrombasthenia (GT) is an inherited platelet function disorder that may manifest with significant bleeding symptoms; in women and girls (W&Gs), heavy menstrual bleeding (HMB) is very common. GT in pregnancy is associated with an increased risk of postpartum haemorrhage (PPH).
Aim: This study highlights the gynaecological and obstetric challenges experienced by W&Gs with GT, and reviews available treatment options.
Avicenna J Med
October 2024
Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States.
Frailty has been associated with inferior outcomes in patients with primary pulmonary hypertension (PPH). There is a lack of national data to assess if hospital frailty risk score (HFRS) is associated with worse inpatient outcomes in PPH. Our retrospective study used the Nationwide Readmission Database (NRD).
View Article and Find Full Text PDF